FINWIRES · TerminalLIVE
FINWIRES

$OABI

3 stories mentioning OABIUpdated just now

Every FINWIRES story that references OABI, newest first.

Sectors

Sector Update: Healthcare Stocks Softer Late Afternoon

Healthcare stocks were lower late Monday afternoon, with the NYSE Healthcare Index down 0.3% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.2%.The iShares Biotechnology ETF (IBB) added 1.8%.In corporate news, OmniAb (OABI) unveiled a partnership with Eli Lilly (LLY) on a new ion-channel drug discovery program, while raising its fiscal 2026 cash and cash equivalents guidance. OmniAb shares jumped nearly 13%, and Lilly was up 0.4%.Freenome (FRNM) shares surged past 12% after Jefferies initiated coverage of the stock with a buy rating and a price target of $17.Argenx (ARGX) shares climbed 16% after the company said a phase 3 study evaluating its experimental drug Vyvgart Hytrulo in adults with autoimmune myositis met its main goal.EyePoint (EYPT) shares tumbled 67% after it said its phase 3 Lugano trial testing Duravyu in people with wet age-related macular degeneration failed to achieve its primary endpoint.

$ARGX$EYPT$FRNM$LLY$OABI
Sectors

Sector Update: Healthcare

Healthcare stocks were lower late Monday afternoon, with the NYSE Healthcare Index down 0.2% and the State Street Health Care Select Sector SPDR ETF (XLV) shedding 0.3%.The iShares Biotechnology ETF (IBB) added 1.7%.In corporate news, OmniAb (OABI) unveiled a partnership with Eli Lilly (LLY) on a new ion-channel drug discovery program, while raising its fiscal 2026 cash and cash equivalents guidance. OmniAb shares jumped 12%, and Lilly was up 0.4%.

$LLY$OABI
Wire

Top Midday Gainers

OmniAb (OABI) unveiled a partnership with Eli Lilly (LLY) on a new ion-channel drug discovery program, while raising its fiscal 2026 cash and cash equivalents guidance.Shares of OmniAb jumped over 11%, with intraday trading volume rising to more than 16.4 million from the stock's daily average of about 647,000.Meanwhile, B. Riley raised its price target for RCM Technologies' (RCMT) shares to $45 from $40 while keeping its buy rating.Shares climbed 13% amid an increase in intraday trading volume to over 320,000 from a daily average of about 63,000.Nvidia (NVDA) has reported a $29.99 billion stake in Intel (INTC) and a $20.98 billion stake in Space Exploration Technologies (SPCX) as of June 30, according to a Form 13F filed Friday with the US Securities and Exchange Commission.Shares of SpaceX rose 6%, with intraday trading volume at over 84.5 million, versus the stock's daily average of about 122.1 million.Price: $3.78, Change: $+0.40, Percent Change: +11.83%

$INTC$LLY$NVDA$OABI$RCMT$SPCX

Track with the FINWIRES app suite